JoAnne Wright MF3 Reproduction
Activity
Tutorial
Tutorial
JoAnne is a 28-year-old G4T1A2L1 Inuk from Baker Lake, Nunavut. Her last menstrual period was February 11. She has a regular, 28-day cycle and had a positive home urine test on March 14. She tells you that she is concerned because she had a DVT in her last pregnancy and was told that she has antiphospholipid antibody syndrome. She has been on warfarin since her son was born 2 years ago. She had 2 miscarriages at 8 and 10 weeks prior to her son being born. She is concerned about the effect of the medicine on her baby and also her risk of developing another clot.
Curriculum Block
Medical Foundation 3 / Part 3 / Reproduction and Pregnancy / Week 3
- Indicates most relevant
Objectives
General Objectives
- Explain the normal physiological adaptations to pregnancy.
- Define a teratogen.
- Compare and contrast warfarin and low molecular weight heparin to illustrate the effects of a teratogen on the developing fetus.
- Describe the course of normal pregnancy and common causes of deviation from this course.
Global Objectives
Assessments
End-Unit Tutorial Assessment
Concept Application Exercise (CAE)
Tags
Basic Sciences
Classification
Embryology
Genetics
Immunology
Pharmacology
Physiology
Curriculum Block
Medical Foundation 3
Part 3
Reproduction and Pregnancy
Week 3
Curriculum Week
Part 3
Week 7
Discipline
Genetics
Hematology
Indigenous Health
Obstetrics and Gynecology
Pharmacology
Reproductive Medicine
Longitudinal Discipline
Indigenous Health
Priority Groups
MCC Presentations
Concepts of Health and Its Determinants
Early Pregnancy Loss / Spontaneous Abortion
Indigenous Health
Prenatal Care
Prevention of Venous Thrombosis
McMaster Program Competencies
1.3 Interpret laboratory data, imaging studies, and other tests required for the area of practice
1.4 Make informed decision about diagnostic and therapeutic interventions based on patient information and preferences, up-to-date scientific evidence, and clinical judgment
1.7 Counsel and educate patients and their families to empower them to participate in their care and enable shared decision-making
1.8 Provide appropriate referral of patients including ensuring continuity of care throughout transitions between providers or settings, and following up on patient progress and outcomes
2.2 Apply biomedical scientific principles fundamental to health care for patients and populations.
2.4 Apply principles of epidemiological sciences to the identification of health problems, risk factors, treatment strategies, resource allocation, and disease prevention/health promotion efforts for patients and populations
2.5 Apply principles of socio-behavioural sciences to the provision of patient care, including assessment of the impact of psychosocial and cultural influences on health, disease, care-seeking, care concordance, care adherence and barriers to and attitudes toward care.
4.1 Communicate effectively with patients, families, and the public, as appropriate, across a broad range of socioeconomic and sociocultural backgrounds
4.2 Participate in the education of patients, families, students, trainees, peers and other health professionals
6.6 Coordinate patient care within the health care system relevant to a variety of clinical specialties
MeSH
Adaptation, Physiological [G07.025]
Antiphospholipid Syndrome [C20.111.197]
Blood Coagulation [G09.188.124.560.150]
Embryonic and Fetal Development [G08.686.784.170]
Embryonic Development [G08.686.784.170.104]
Heparin [D09.698.373.400]
Indigenous Canadians [M01.270.968.500.600.375]
Indigenous Canadians [M01.270.968.500.600.375]
Infectious Disease Transmission, Vertical [N06.850.310.425]
Inuit [M01.270.968.500.600.375.500]
Organogenesis [G07.345.500.325.377]
Pregnancy [G08.686.784.769]
Prenatal Care [E02.760.786]
Prenatal Diagnosis [E01.370.378.630]
Teratogens [D27.888.569.864]
Teratology [H01.158.100.529.500]
Ultrasonography, Prenatal [E01.370.378.630.865]
Venous Thrombosis [C14.907.355.830.925]
Warfarin [D03.438.150.446.520.914]
Women's Health [N01.400.900]